StockWatch
·
Pharmaceuticals
Board Meeting21 May 2026, 05:51 pm

Biofil Chemicals Board Meeting on May 30, 2026

AI Summary

Biofil Chemicals & Pharmaceuticals Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results for the fourth quarter and financial year ended March 31, 2026. The trading window will open 48 hours after the declaration of the results. The company has also submitted the information in XBRL mode.

Key Highlights

  • Board meeting scheduled on May 30, 2026, to approve audited financial results.
  • Audited financial results for Q4 and FY26 to be considered.
  • Trading window to open 48 hours after results declaration.
  • Information submitted in XBRL and PDF modes.